Anxo Pharmaceutical Co., Ltd. (6677)
Market Closed
11 Aug, 05:30
TWSE 
NT$
16. 45
+0.15
+0.9202%
NT$
- Market Cap
- P/E Ratio
0.03% Div Yield
16,305 Volume
- Eps
NT$ 16.3
Previous Close Want to track 6677 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Anxo Pharmaceutical Co., Ltd. (6677) Statistics
Valuation metrics
Market Cap -
Enterprise value 1.27B
Trailing P/E (ttm) -26.64
Forward P/E -
PEG ratio -0.52
Price/Sales (ttm) 1.08
Price/Book (mrq) 0.92
Enterprise Value/Revenue 1.5
Enterprise Value/EBITDA 38.97
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 22.03K
Average volume (90 days) 56.08K
Price summary
52-Week low 15.5
52-Week high 30.5
Beta -
50-Day moving average 16.63
200-Day moving average 18.4
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 15 Jun 2026
Ex-Dividend Date 26 May 2026
Last split factor 259:250
Last split Date 11 Jul 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.04%
Operating margin -0.05%
Operational effectiveness
Return on assets -0.02%
Return on equity -0.03%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 15.03
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.61
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.91
Total debt (mrq) -
Total Debt/Equity (mrq) 0.74
Current ratio (mrq) 1.57%
Book value per share (mrq) 19.75
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
